Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction

Jiang,Guo-Tao; Chen,Xiao; Li,Dong; An,Hui-Xia; Jiao,Jun-Dong

doi:10.3892/mmr.2014.2323

Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction

Authors:
- Guo-Tao Jiang
- Xiao Chen
- Dong Li
- Hui-Xia An
- Jun-Dong Jiao
View Affiliations

Affiliations: Department of Nephrology, Second Afﬁliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China
Published online on: June 13, 2014 https://doi.org/10.3892/mmr.2014.2323
Pages: 1501-1508

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine the protective effects of the urinary trypsin inhibitor ulinastatin (UTI) on renal interstitial inflammation and fibrosis in rats subjected to unilateral ureteral obstruction (UUO). A total of 24 male Wistar rats were randomly divided into the three groups; the sham operation (SOR) group (n=8), the UUO group (n=8) and the UUO+UTI group (post‑UUO UTI treatment, n=8). UUO was performed with complete ligation of the left ureter. As a medical intervention, saline (4 ml kg‑1 d‑1) and UTI (40000 units kg‑1 d‑1) were injected, respectively, into the animals of the corresponding groups on day one following surgery. The rats in all three groups were euthanized on day seven post surgery. Blood samples were harvested for blood urea nitrogen (BUN) and serum creatinine (Scr) content measurements. The degree of interstitial pathological changes in the tissues from the obstructed kidneys were observed through hematoxylin and eosin (H&E) and Masson staining. The CD68+ macrophage amount, tumor necrosis factor‑α (TNF‑α), interleukin 1β (IL‑1β), nuclear factor‑κB (NF‑κB), transforming growth factor‑β1 (TGF‑β1) and type I collagen (Col‑I) levels were examined immunohistochemically. The protein expression levels of NF‑κB were examined using western blot analysis. Total superoxide dismutase (SOD) activity and malondialdehyde (MDA) content of homogenates were measured spectrophotometrically. The results revealed that ulinastatin had no statistically significant effect on the BUN and Scr levels (P>0.05). However, in comparison with the SOR group, the UUO group exhibited significantly more severe renal interstitial pathological injury in terms of tubular dilation, epithelial atrophy, renal interstitial inflammatory cell infiltration and proliferation of fibrous tissues, as well as significantly elevated levels of interstitial CD68+ macrophages, IL‑1β, TNF‑α, NF‑κB, TGF‑β1 and Col‑I (P<0.01). UTI treatment significantly reduced UUO‑induced renal interstitial damage with reduced levels of interstitial CD68+ macrophages, IL‑1β, TNF‑α, NF‑κB, TGF‑β1 and Col‑I and MDA (P<0.05), and increased SOD levels (P<0.05). In conclusion, the present study indicated that UTI is able to effectively inhibit UUO‑side renal interstitial inflammatory reaction and fibrosis in UUO‑inflicted rats.

View Figures

View References

1	Noronha IL, Fujihara CK and Zatz R: The inflammatory component in Progressive renal disease - are interventions possible? Nephrol Dial Transplant. 17:363–368. 2002. View Article : Google Scholar : PubMed/NCBI
2	Filiopoulos V and Vlassopoulos D: Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets. 8:369–382. 2009. View Article : Google Scholar : PubMed/NCBI
3	Chevalier RL, Forbes MS and Thornhill BA: Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75:1145–1152. 2009. View Article : Google Scholar : PubMed/NCBI
4	Chevalier RL, Thornhill BA, Forbes MS and Kiley SC: Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol. 25:687–697. 2010. View Article : Google Scholar : PubMed/NCBI
5	Grande MT, Pérez-Barriocanal F and López-Novoa JM: Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy. J Inflamm (Lond). 7:192010.
6	Fries E and Blom AM: Bikunin - not just a plasma proteinase inhibitor. Int J Biochem Cell Biol. 32:125–137. 2000. View Article : Google Scholar : PubMed/NCBI
7	Fang Y, Xu P, Gu C, et al: Ulinastatin improves pulmonary function in severe burn-induced acute lung injury by attenuating inflammatory response. J Trauma. 71:1297–1304. 2011. View Article : Google Scholar : PubMed/NCBI
8	Xu M, Wen XH, Chen SP, An XX and Xu HY: Addition of ulinastatin to preservation solution promotes protection against ischemia-reperfusion injury in rabbit lung. Chin Med J (Engl). 124:2179–2183. 2011.PubMed/NCBI
9	Gao C, Huan J, Li W and Tang J: Protective effects of Ulinastatin on pancreatic and renal damage in rats following early scald injury. Burns. 35:547–552. 2009. View Article : Google Scholar : PubMed/NCBI
10	Yang Q, Liu X, Liu M, Zhang L and Guan Y: Ulinastatin-mediated protection against zymosan-induced multiple organ dysfunction in rats. Biologicals. 38:552–556. 2010. View Article : Google Scholar : PubMed/NCBI
11	Katoh H, Ishikawa H, Hasegawa M, et al: Protective effect of urinary trypsin inhibitor on the development of radiation-induced lung fibrosis in mice. J Radiat Res. 51:325–332. 2010. View Article : Google Scholar : PubMed/NCBI
12	Lange-Sperandio B, Trautmann A, Eickelberg O, et al: Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol. 171:861–871. 2007. View Article : Google Scholar : PubMed/NCBI
13	Lu J, Chen YP, Wan R, Guo CY and Wang XP: Protective effects of ulinastatin on acute liver failure induced by lipopolysaccharide/D-galactosamine. Dig Dis Sci. 57:399–404. 2012. View Article : Google Scholar : PubMed/NCBI
14	Shin IW, Jang IS, Lee SM, et al: Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol. 61:499–505. 2011. View Article : Google Scholar : PubMed/NCBI
15	Nam NH: Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem. 6:945–951. 2006. View Article : Google Scholar : PubMed/NCBI
16	Baugé C, Beauchef G, Leclercq S, et al: NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression. J Cell Mol Med. 12:1754–1766. 2008.PubMed/NCBI
17	Gao C, Li R and Wang S: Ulinastatin protects pulmonary tissues from lipopolysaccharide-induced injury as an immunomodulator. J Trauma Acute Care Surg. 72:169–176. 2012.PubMed/NCBI
18	Wu YJ, Ling Q, Zhou XH, et al: Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation. Hepatobiliary Pancreat Dis Int. 8:53–58. 2009.
19	Ning XH, Ge XF, Cui Y and An HX: Ulinastatin inhibits unilateral ureteral obstruction-induced renal interstitial fibrosis in rats via transforming growth factor β (TGF-β)/Smad signalling pathways. Int Immunopharmacol. 15:406–413. 2013.PubMed/NCBI
20	Ferenbach D, Kluth DC and Hughes J: Inflammatory cells in renal injury and repair. Semin Nephrol. 27:250–259. 2007. View Article : Google Scholar : PubMed/NCBI
21	Spann KM, Tran KC and Collins PL: Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J Virol. 7:5353–5362. 2005. View Article : Google Scholar
22	Esteban V, Lorenzo O, Rupérez M, et al: Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol. 15:1514–1529. 2004. View Article : Google Scholar : PubMed/NCBI
23	Miyajima A, Kosaka T, Seta K, et al: Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol. 169:1559–1563. 2003. View Article : Google Scholar : PubMed/NCBI
24	Yeh YC, Wei WC, Wang YK, et al: Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol. 177:1743–1754. 2010. View Article : Google Scholar
25	Shirakihara T, Horiguchi K, Miyazawa K, et al: TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J. 30:783–795. 2011.
26	Phanish MK, Wahab NA, Colville-Nash P, Hendry BM and Dockrell ME: The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbetal responses in human proximal-tubule epithelial cells. Biochem J. 393:601–607. 2006. View Article : Google Scholar : PubMed/NCBI